Antioxidant synthetic peptides counteracting hyperglycaemia induced endothelial cell dysfunction

Int J Cardiol. 2020 Jun 1:308:82-83. doi: 10.1016/j.ijcard.2020.03.051. Epub 2020 Mar 23.

Authors

Colin E Murdoch¹, Elena De Falco²

Affiliations

¹ Systems Medicine, School of Medicine, University of Dundee, Dundee, Scotland DD1 9SY, UK. Electronic address: c.z.murdoch@dundee.ac.uk.
² Sapienza University of Rome, Faculty of Pharmacy and Medicine, Department of Medical-Surgical Sciences and Biotechnologies, Italy; Mediterranea Cardiocentro, Naples, Italy. Electronic address: elena.defalco@uniroma1.it.

PMID: 32247574
DOI: 10.1016/j.ijcard.2020.03.051

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antioxidants
Cell Survival
Endothelial Cells
Humans
Hyperglycemia*
Peptides
Thioredoxins
Vascular Endothelial Growth Factor Receptor-2

Substances

Antioxidants
Peptides
Thioredoxins
Vascular Endothelial Growth Factor Receptor-2

Grants and funding

16/0005453/DUK_/Diabetes UK/United Kingdom